Our touch resilient biocidal barrier agents have been proven effective against the Coronavirus including the SARS-CoV-2 (COVID-19) strain. Not only do they eliminate the virus they also form a barrier that protects treated surfaces against further infection.
Although laboratory testing is still ongoing to prove the longevity and effectiveness of different formulas on treated surfaces against the SARS-CoV-2 strain, we have already seen some positive results. Testing under controlled conditions showed a barrier solution remained effective against the SARS-CoV-2 (COVID-19) virus on treated surfaces for days after being applied.
Press Release from Goldshield Technologies
Goldshield Technologies’ Groundbreaking Antimicrobial Technology has been found to create a bio barrier successful in eliminating the SARS-CoV-2 (COVID-19) virus on treated medical masks and rubber medical gloves for up to 72 hours
This finding is a huge step in a positive direction for the international healthcare industry in the fight against COVID-19.
The science has shown that COVID-19 can survive on surgical masks for seven days, so the residual impact of Goldshield 5 to mitigate this risk is a major development within the healthcare and first responder sectors. Additionally, more than 50 independent studies were conducted to ensure the efficacy of Goldshield 5 which included three, peer-reviewed, published studies featured in the American Journal of Infection Control.
Working closely with healthcare experts, Goldshield 5 underwent independent testing in a study sponsored by Guilin HBM Health Protections Inc., China’s leading medical mask and glove manufacturer. The results of this study found that when applied to medical masks and gloves, Goldshield 5 created a residual protective bio barrier against the pathogenic COVID-19, killing it on treated medical masks and rubber medical gloves for up to 72 hours.
On the surgical masks treated with Goldshield 5, the COVID-19 inactivation rate was 99.88% kill rate compared to the control group, with a residual kill rate observed by the researchers for a period of three days. The Goldshield 5 treatment on the medical gloves resulted in the inactivation of the COVID-19 virus at a kill rate of 94.87% compared to the control group.
These test results confirm that Goldshield has successfully managed to create a barrier against Covid-19 on surgical masks and gloves which are designed to be waterproof, this is a positive result that shows significant progress in preventing the spread of the virus through human contact.